Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications

Di Chen1, Shuai Ping2, Yushuang Xu1

  • 1Department of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Insights

Non-coding RNAs (ncRNAs) are crucial in gastric cancer (GC) development, influencing immune escape, drug resistance, and stemness. Further research into ncRNAs offers potential for new diagnostic biomarkers and therapeutic targets for this lethal malignancy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastric cancer (GC) is a leading cause of cancer mortality globally, with underlying molecular mechanisms poorly understood.
  • Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are increasingly identified in cancer cells.
  • ncRNAs play essential roles in the occurrence and progression of GC, but their complex functions require further elucidation.

Purpose of the Study:

  • To review recent research on how ncRNAs regulate malignant characteristics of GC.
  • To explore the role of ncRNAs in tumor immune escape, drug resistance, and stemness in GC.
  • To discuss the potential of ncRNAs as diagnostic biomarkers and therapeutic targets for clinical application in GC.

Main Methods:

  • Literature review of recent research on ncRNAs in gastric cancer.
  • Analysis of studies focusing on ncRNA modulation of GC hallmarks.
  • Synthesis of evidence regarding ncRNA applications in GC diagnostics and therapeutics.

Main Results:

  • ncRNAs significantly influence key aspects of GC malignancy, including immune evasion, therapeutic resistance, and cancer stem cell properties.
  • Accumulating evidence highlights the regulatory roles of various ncRNAs in gastric carcinogenesis.
  • The intricate relationships between ncRNAs and GC progression are being uncovered, paving the way for clinical translation.

Conclusions:

  • ncRNAs are critical regulators in gastric cancer development and progression.
  • Understanding ncRNA functionality in GC offers promising avenues for developing novel diagnostic biomarkers and therapeutic strategies.
  • Further investigation into ncRNAs is essential to validate their clinical utility for improved gastric cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K